Information on aspirin

Information on aspirin

Aspirin. For primary prevention is subject to the benefits and disadvantages!

Like other cardiac science science is constantly changing depending on what be or become clear to humans of scientific evidence is examined in clinical trials and is graded in.. As it is now from the civilization is other people have gone to hundreds of years of experience and scientific research. And each generation of paving the glory of human knowledge unless inform. Development of medical development in the treatment and prevention of diseases.

And our conversation today matter everyone especially after over age 50?! Do I need an aspirin? How much dose? And is it better than envelope or not? Is there a difference between men and women? ...Etc ...And wonderful anachronisms that aspirin should be mentioned when the production was initially used to treat fever, joint pain and the doctors warn people at the time of use in heart patients!! And did not know that after 100 years, it will become the most important drugs for preventing and treating heart clots!!

How does aspirin?

There is an important concept is that aspirin prevents formation of a blood clot in the latter stages of the chain configuration lowers the arteries and thus lowers sunken walls cracking on the arteries and then the deposition of platelets and blood clot formation (this point specifically which prevents the aspirin in the prevention of althromboxin material that lead to platelet adhesion and lowers arterial microinjuries bloody on the sunken in the arteries). Therefore, many scholars prefer to be focused on preventing deposition on the arteries lowers starting and not wait until you are in your arteries and lowers its perfect cleavage and then trying to prevent a blood clot in the first stages of composition. And prevention lowers the arterial deposition – is known as-healthy food, exercise and not smoking, medicines lowers pressure and control diabetes. And granted the American Heart Association in 2012 not give aspirin to all persons over a certain age, without exception, because the drug has potentially serious gastrointestinal ulcers are particularly stomach bleeding, therefore we must balance the benefits and disadvantages of present and future in the person and then take the appropriate decision in each case, as stated in the magazine archives internal med January 2012 in the analysis of the studies contained one hundred thousand patients taking aspirin as primary prevention followed six years were By reducing the heart clots around 10% in contrast bleeding was 30% in General, the higher the interest rate the higher rate of bleeding

 

Aspirin envelope even stomach bleeding

Some people believe that aspirin protects against bleeding envelope. This concept is not valid because the bleeding is the effect of aspirin on platelets in all parts of the body which may cause bleeding in the brain or the nose or gastrointestinal (clearly visible Monday quality or causing chronic anemia microscope, particularly in the elderly) or bleeding from the urinary tract as well as inhibition of manufacturing albrostasayklin that protect the stomach wall.

What is the difference between primary prevention and secondary prevention and treatment?

And we must distinguish between the concepts of primary prevention and secondary prevention and treatment ... The primary prevention: taking aspirin to correct human healthy which was previous clots – whether he has or not chronic disease-prevention of heart and brain clots and effectiveness in the range of 10% to emancipation involves two aspects in this context.

Secondary prevention: taking aspirin to him former clot in his heart or his brain or legs (arterial and venous is) to prevent a blood clot again. And effectiveness of about 20%.

Treatment is for the man who has suffered a severe heart or brain now needs to take aspirin to reduce the possibility of his death in the stroke and its expansion and its effectiveness in that case about 25%.

Thus it is clear that aspirin more effective treatment in secondary prevention, secondary prevention in primary prevention because of decreased risk.

It is recommended that you take aspirin for primary prevention of having all of the following conditions:

1. men over 50 and women over 60 years

2. does not have symptoms of digestive ulcer or bleeding in the brain or stomach or other body parts or information of bleeding such as hemophilia disease and cirrhosis or thrombocytopenia less than thirty thousand.

3. to know that it is possible to get to the person bleeding in the stomach or duodenum caused by aspirin and that the person prefers heart clot prevention against exposure to the likelihood of stomach bleeding, which can be in some cases more serious than some heart clots, known as well as the difference between the statistical usefulness of prevention and dangerous complications are very close in this group of people.

4. no sensitive information for aspirin.

5. the likelihood of a stroke at heart over the next year more than 1% according to table fermnkham.

6. the person able and willing to take medication daily and continue for many years to get the benefit of prevention.

It is advised to take aspirin for secondary prevention:

1. have previous clots in the heart or brain or arterial clots in the legs

2. that the bleeding has stomach or other body parts below the usefulness of taking the drug.

Conclusion: aspirin medication effective in treating people with severe blood clots as well as in secondary prevention. Either primary prevention, a subject must be weighed the benefits and detriments on a case-by-case basis under the conditions mentioned above and after extensive discussion between patient and physician and continuous follow-up simply because the potential benefits of the drug and its very similar in these patients.